Biogen Inc.
BIIB · Large Cap · NASDAQ · Healthcare · Drug Manufacturers - General
$225.41+$6.34 (+2.89%)
Market closed · opens in 9h 58mNext open: Wednesday, Sep 23, 9:30 AM ETFree AI brief
Get the full brief on BIIB
Free to track. No card required. Usually ready in 10-15 minutes.
Where BIIB sits today
Price, momentum, and the numbers behind the story.
52-week range
Low$123.38
High$219.72
Today $225.41
RSI (14)
59.9Neutral
03070100
Stocksbrew score
59/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Lowest
$175
Current price
$225.41
Median target
$240
Highest
$300
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
RevenueTrend
✓ Good things about the company
Forward P/E
Favorable · 28% below avg
16.26x
Price / FCF
Strong · Cash flow supports price
11.81x
EV / EBITDA
Strong · Earnings support price
11.58x
Debt / equity
Favorable · 0.35 - strong leverage
0.44x
Current ratio
Strong · Good liquidity position
1.87x
⚠ Things to watch
ROE
Needs attention · Unfavorable
4.6%
How it stacks up against its peers
BIIB against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $31.84B | 38.2 | +0.3% | 59 |
 | $9.95B | 18.9 | +19.7% | 78 |
 | $33.72B | 35.3 | +15.5% | 78 |
 | $4.12B | 12.4 | +13.5% | 78 |
 | $1.09T | 39.2 | +49.6% | 77 |
What is moving BIIB
Every story that touched the stock this week, newest first.